Orbimed Advisors LLC Pmv Pharmaceuticals, Inc. Call Options Transaction History
Orbimed Advisors LLC
- $4.15 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PMVP
# of Institutions
97Shares Held
43.4MCall Options Held
500Put Options Held
100-
Arrow Mark Colorado Holdings LLC Denver, CO2.8MShares$4.46 Million0.06% of portfolio
-
Sio Capital Management, LLC New York, NY2.71MShares$4.31 Million1.64% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$4.18 Million0.54% of portfolio
-
Alkeon Capital Management LLC New York, NY2.35MShares$3.73 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$3.63 Million0.0% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $72.5M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...